Last reviewed · How we verify
Suvorexant 10 mg
Suvorexant 10 mg is a Small molecule drug developed by Walter Reed Army Institute of Research (WRAIR). It is currently FDA-approved. Also known as: Belsomra, belsomra 10mg.
Suvorexant 10 mg is a medication that has been studied in clinical trials for various conditions, including insomnia, hepatic insufficiency, and alcohol use disorder. It is a single-dose study to investigate the pharmacokinetics of suvorexant in participants with hepatic insufficiency, and it has also been studied in combination with alcohol and as a placebo in other trials.
At a glance
| Generic name | Suvorexant 10 mg |
|---|---|
| Also known as | Belsomra, belsomra 10mg |
| Sponsor | Walter Reed Army Institute of Research (WRAIR) |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Orexin s Role in the Neurobiology of Substance Use Disorder (NA)
- A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098) (PHASE3)
- Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors (PHASE4)
- The Effects of Orexin Antagonism on Fear Extinction in PTSD (PHASE4)
- Evaluation of Suvorexant for Reduction of Brain Reactivity in Patients With Cannabis Use Disorder (Pilot Study) (PHASE4)
- Suvorexant and Alcohol (EARLY_PHASE1)
- Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking (PHASE2)
- Suvorexant and Sleep/Delirium in ICU Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Suvorexant 10 mg CI brief — competitive landscape report
- Suvorexant 10 mg updates RSS · CI watch RSS
- Walter Reed Army Institute of Research (WRAIR) portfolio CI
Frequently asked questions about Suvorexant 10 mg
What is Suvorexant 10 mg?
Who makes Suvorexant 10 mg?
Is Suvorexant 10 mg also known as anything else?
What development phase is Suvorexant 10 mg in?
Related
- Manufacturer: Walter Reed Army Institute of Research (WRAIR) — full pipeline
- Also known as: Belsomra, belsomra 10mg
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing